TABLE 1.
Intervention Characteristics
| Target Population | Centralized Reminder and Recall, 11- to 17-y-Olds Included in Immunization Information System | School-Located Vaccination, 11- to 13-y-Olds in Public Middle Schools | QI Visits, 11- to 17-y-Olds With Participating Providers |
|---|---|---|---|
| Expected reach | |||
| 11- to 13-y-olds | 249 400 | 247 254 | 246 500 |
| 14- to 17-y-olds | 219 300 | 0 | 216 750 |
| Expected improvement in HPV vaccine initiation rate,a % (range) | |||
| Girls 11–13 | 2.0 (1.0–6.0) | 13.0 (2.0–17.7) | 2.6 (0.9–4.2) |
| Boys 11–13 | 5.0 (1.0–6.0) | 13.0 (2.0–17.7) | 2.6 (0.9–3.1) |
| Girls 14–17 | 3.0 (1.9–6.0) | — | 0.0 (0.0–3.3) |
| Boys 14–17 | 2.0 (0.3–6.0) | — | 0.0 (0.0–8.0) |
| Expected improvement in HPV vaccine follow-through rate,b % (range) | |||
| Girls 11–13 | 8.0 (0.0–16.6) | 4.0 (0.0–18) | 0.0 (0.0–1.3) |
| Boys 11–13 | 8.0 (0.0–16.6) | 4.0 (0.0–18) | 0.0 (0.0–1.3) |
| Girls 14–17 | 8.0 (0.0–16.6) | — | 0.0 (0.0–1.3) |
| Boys 14–17 | 8.0 (0.0–16.6) | — | 0.0 (0.0–1.3) |
| Cost per individual reached,c $ (range) | 2.10 (1.33–2.70) | 12.29 (9.22–15.36) | 0.14 (0.09–0.60) |
—, not applicable.
a
Estimated percentage point increase in vaccination in unvaccinated individuals.
b
Estimated percentage point increase in vaccine follow-through rates in vaccine initiators.
c
Costs are updated to 2018 US dollars by using the Consumer Price Index.28